aTyr Pharma Ownership 2024 | Who Owns aTyr Pharma Now?


OverviewForecastRevenueFinancialsChartTranscripts

Institutional Ownership

51.34%

Insider Ownership

2.62%

Retail Ownership

46.04%

Institutional Holders

22.00

aTyr Pharma Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
FEDERATED HERMES, INC.22.20%0.05%14,666,6004,497,00044.22%22,879,896,000Jun 30, 2024
FMR LLC15.67%0.00%10,351,6411,428,43116.01%16,148,560Jun 30, 2024
LOGOS GLOBAL MANAGEMENT LP4.54%0.38%3,000,000-100,000-3.23%4,680,000Jun 30, 2024
VANGUARD GROUP INC4.01%0.00%2,652,157--4,137,365Jun 30, 2024
TIKVAH MANAGEMENT LLC3.72%1.25%2,460,833--3,838,899Jun 30, 2024
CHECKPOINT CAPITAL L.P.2.95%1.83%1,946,477500,00034.57%3,036,504Jun 30, 2024
ALYESKA INVESTMENT GROUP, L.P.2.83%0.02%1,867,633362,07824.05%2,913,507Jun 30, 2024
WOODLINE PARTNERS LP2.55%0.03%1,683,1621,8830.11%2,625,733Jun 30, 2024
BLACKROCK INC.2.11%-1,392,07427,1941.99%2,171,636Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC1.96%0.00%1,293,81420,9591.65%2,018,350Jun 30, 2024
ADAGE CAPITAL PARTNERS GP, L.L.C.1.51%0.00%1,000,0001,000,000100.00%1,560,000Jun 30, 2024
GHOST TREE CAPITAL, LLC1.21%0.39%800,000200,00033.33%1,248,000Jun 30, 2024
TANG CAPITAL MANAGEMENT LLC1.02%0.11%671,134200,00042.45%1,046,969Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC1.00%0.00%662,68467,57311.35%1,034,003Jun 30, 2024
GSA CAPITAL PARTNERS LLP0.49%0.04%322,46098,31343.86%503,000Jun 30, 2024
SUPERSTRING CAPITAL MANAGEMENT LP0.47%0.62%313,028313,028100.00%488,324Jun 30, 2024
STATE STREET CORP0.25%-168,3081,5000.90%262,560,000Jun 30, 2024
DIMENSIONAL FUND ADVISORS LP0.22%0.00%145,524-51,220-26.03%227,017Jun 30, 2024
NORTHERN TRUST CORP0.18%-118,45619,29019.45%184,791,000Jun 30, 2024
BANK OF AMERICA CORP /DE/0.18%-117,037-39,138-25.06%182,578Jun 30, 2024

aTyr Pharma's largest institutional shareholder is FEDERATED HERMES, INC., holding 22.20% of the company's total share outstanding, currently valued at $22.88B. The top 10 institutional shareholders own together 62.52% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
CHECKPOINT CAPITAL L.P.2.95%1.83%1,946,477500,00034.57%3,036,504Jun 30, 2024
TIKVAH MANAGEMENT LLC3.72%1.25%2,460,833--3,838,899Jun 30, 2024
SUPERSTRING CAPITAL MANAGEMENT LP0.47%0.62%313,028313,028100.00%488,324Jun 30, 2024
GHOST TREE CAPITAL, LLC1.21%0.39%800,000200,00033.33%1,248,000Jun 30, 2024
LOGOS GLOBAL MANAGEMENT LP4.54%0.38%3,000,000-100,000-3.23%4,680,000Jun 30, 2024
TANG CAPITAL MANAGEMENT LLC1.02%0.11%671,134200,00042.45%1,046,969Jun 30, 2024
FEDERATED HERMES, INC.22.20%0.05%14,666,6004,497,00044.22%22,879,896,000Jun 30, 2024
GSA CAPITAL PARTNERS LLP0.49%0.04%322,46098,31343.86%503,000Jun 30, 2024
WOODLINE PARTNERS LP2.55%0.03%1,683,1621,8830.11%2,625,733Jun 30, 2024
ALYESKA INVESTMENT GROUP, L.P.2.83%0.02%1,867,633362,07824.05%2,913,507Jun 30, 2024
ALTERNA WEALTH MANAGEMENT, INC0.02%0.01%10,000--15,600Jun 30, 2024
MAIN STREET FINANCIAL SOLUTIONS, LLC0.10%0.01%67,72533,25096.45%105,651Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC1.96%0.00%1,293,81420,9591.65%2,018,350Jun 30, 2024
VIRTU FINANCIAL LLC0.04%0.00%27,96627,966100.00%44,000Jun 30, 2024
ADAGE CAPITAL PARTNERS GP, L.L.C.1.51%0.00%1,000,0001,000,000100.00%1,560,000Jun 30, 2024
FARTHER FINANCE ADVISORS, LLC0.05%0.00%30,4231000.33%47,460Jun 30, 2024
FMR LLC15.67%0.00%10,351,6411,428,43116.01%16,148,560Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)0.04%0.00%27,33821,071336.22%42,647Jun 30, 2024
SCHONFELD STRATEGIC ADVISORS LLC0.06%0.00%38,90018,40089.76%60,684Jun 30, 2024
D.A. DAVIDSON & CO.0.04%0.00%27,8501,5005.69%43,446,000Jun 30, 2024

The largest aTyr Pharma shareholder by % of total assets is CHECKPOINT CAPITAL L.P.. The company owns 1.95M shares of aTyr Pharma (LIFE), representing 1.83% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
FEDERATED HERMES, INC.22.20%0.05%14,666,6004,497,00044.22%22,879,896,000Jun 30, 2024
FMR LLC15.67%0.00%10,351,6411,428,43116.01%16,148,560Jun 30, 2024
ADAGE CAPITAL PARTNERS GP, L.L.C.1.51%0.00%1,000,0001,000,000100.00%1,560,000Jun 30, 2024
CHECKPOINT CAPITAL L.P.2.95%1.83%1,946,477500,00034.57%3,036,504Jun 30, 2024
ALYESKA INVESTMENT GROUP, L.P.2.83%0.02%1,867,633362,07824.05%2,913,507Jun 30, 2024
SUPERSTRING CAPITAL MANAGEMENT LP0.47%0.62%313,028313,028100.00%488,324Jun 30, 2024
TANG CAPITAL MANAGEMENT LLC1.02%0.11%671,134200,00042.45%1,046,969Jun 30, 2024
GHOST TREE CAPITAL, LLC1.21%0.39%800,000200,00033.33%1,248,000Jun 30, 2024
GSA CAPITAL PARTNERS LLP0.49%0.04%322,46098,31343.86%503,000Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC1.00%0.00%662,68467,57311.35%1,034,003Jun 30, 2024
MILLENNIUM MANAGEMENT LLC0.16%0.00%106,43243,95170.34%166,034Jun 30, 2024
MAIN STREET FINANCIAL SOLUTIONS, LLC0.10%0.01%67,72533,25096.45%105,651Jun 30, 2024
VIRTU FINANCIAL LLC0.04%0.00%27,96627,966100.00%44,000Jun 30, 2024
BLACKROCK INC.2.11%-1,392,07427,1941.99%2,171,636Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)0.04%0.00%27,33821,071336.22%42,647Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC1.96%0.00%1,293,81420,9591.65%2,018,350Jun 30, 2024
NORTHERN TRUST CORP0.18%-118,45619,29019.45%184,791,000Jun 30, 2024
SCHONFELD STRATEGIC ADVISORS LLC0.06%0.00%38,90018,40089.76%60,684Jun 30, 2024
VERITION FUND MANAGEMENT LLC0.02%0.00%12,67512,675100.00%19,773Jun 30, 2024
AMERICAN CENTURY COMPANIES INC0.09%0.00%60,4876,44411.92%94,360Jun 30, 2024

As of Jun 30 2024, aTyr Pharma's largest institutional buyer is FEDERATED HERMES, INC.. The company purchased 4.50M stocks of LIFE, valued at $22.88B.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
OCTAGON CAPITAL ADVISORS LP----700,000-100.00%-Jun 30, 2024
BARCLAYS PLC----604,299-100.00%-Jun 30, 2024
GOLDMAN SACHS GROUP INC----217,233-100.00%-Jun 30, 2024
MARSHALL WACE, LLP----158,619-100.00%-Jun 30, 2024
LOGOS GLOBAL MANAGEMENT LP4.54%0.38%3,000,000-100,000-3.23%4,680,000Jun 30, 2024
PALE FIRE CAPITAL SE----91,232-100.00%-Jun 30, 2024
XTX TOPCO LTD----83,328-100.00%-Jun 30, 2024
KINGSWOOD WEALTH ADVISORS, LLC----60,000-100.00%-Jun 30, 2024
DIMENSIONAL FUND ADVISORS LP0.22%0.00%145,524-51,220-26.03%227,017Jun 30, 2024
JUMP FINANCIAL, LLC----49,904-100.00%-Jun 30, 2024
ACADIAN ASSET MANAGEMENT LLC----45,366-100.00%-Jun 30, 2024
Y-INTERCEPT (HONG KONG) LTD----43,892-100.00%-Jun 30, 2024
BANK OF AMERICA CORP /DE/0.18%-117,037-39,138-25.06%182,578Jun 30, 2024
SG AMERICAS SECURITIES, LLC----28,256-100.00%-Jun 30, 2024
UBS GROUP AG----20,192-100.00%-Jun 30, 2024
MORGAN STANLEY--1-19,717-99.99%2Jun 30, 2024
CTC ALTERNATIVE STRATEGIES, LTD.----17,600-100.00%-Jun 30, 2024
TWO SIGMA SECURITIES, LLC----17,487-100.00%-Jun 30, 2024
PRUDENTIAL FINANCIAL INC----16,000-100.00%-Jun 30, 2024
JPMORGAN CHASE & CO0.03%-20,686-13,168-38.90%32,270Jun 30, 2024

As of Jun 30 2024, aTyr Pharma's biggest institutional seller is OCTAGON CAPITAL ADVISORS LP. The company sold -0.70M shares of LIFE, valued at -.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ADAGE CAPITAL PARTNERS GP, L.L.C.1.51%0.00%1,000,0001,000,000100.00%1,560,000Jun 30, 2024
SUPERSTRING CAPITAL MANAGEMENT LP0.47%0.62%313,028313,028100.00%488,324Jun 30, 2024
VERITION FUND MANAGEMENT LLC0.02%0.00%12,67512,675100.00%19,773Jun 30, 2024
SACHETTA, LLC0.00%0.00%150150100.00%297Jun 30, 2024

aTyr Pharma's largest new institutional shareholder by number of shares is ADAGE CAPITAL PARTNERS GP, L.L.C., purchased 1.00M shares, valued at $1.56M, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
OCTAGON CAPITAL ADVISORS LP----700,000-100.00%-Jun 30, 2024
BARCLAYS PLC----604,299-100.00%-Jun 30, 2024
GOLDMAN SACHS GROUP INC----217,233-100.00%-Jun 30, 2024
MARSHALL WACE, LLP----158,619-100.00%-Jun 30, 2024
PALE FIRE CAPITAL SE----91,232-100.00%-Jun 30, 2024
XTX TOPCO LTD----83,328-100.00%-Jun 30, 2024
KINGSWOOD WEALTH ADVISORS, LLC----60,000-100.00%-Jun 30, 2024
JUMP FINANCIAL, LLC----49,904-100.00%-Jun 30, 2024
ACADIAN ASSET MANAGEMENT LLC----45,366-100.00%-Jun 30, 2024
Y-INTERCEPT (HONG KONG) LTD----43,892-100.00%-Jun 30, 2024
SG AMERICAS SECURITIES, LLC----28,256-100.00%-Jun 30, 2024
UBS GROUP AG----20,192-100.00%-Jun 30, 2024
CTC ALTERNATIVE STRATEGIES, LTD.----17,600-100.00%-Jun 30, 2024
TWO SIGMA SECURITIES, LLC----17,487-100.00%-Jun 30, 2024
PRUDENTIAL FINANCIAL INC----16,000-100.00%-Jun 30, 2024
TWO SIGMA INVESTMENTS, LP----10,088-100.00%-Jun 30, 2024

aTyr Pharma's largest sold out institutional shareholder by shares sold is OCTAGON CAPITAL ADVISORS LP, sold -0.70M shares, valued at -, as of undefined.

aTyr Pharma Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
BNY Mellon U.S. Mortgage Fund, Inc.0.80%2,575,000--Apr 30, 2022
Federated Hermes Equity Funds0.52%10,049,000--Jan 31, 2024
BNY Mellon Investment Funds VII, Inc.0.43%491,485-8,514-1.70%Apr 30, 2022
MORGAN STANLEY U.S. GOVERNMENT SECURITIES TRUST0.34%1,375,000--Mar 31, 2024
JANUS ASPEN SERIES0.29%12,590,000--Dec 31, 2023
JANUS ASPEN SERIES0.27%11,845,774--Dec 31, 2023
BBH Trust0.25%23,600,000--Jan 31, 2024
Guggenheim Strategy Funds Trust0.20%2,015,088--Dec 31, 2023
JANUS INVESTMENT FUND0.15%46,192,000--Dec 31, 2023
JOHN HANCOCK INCOME SECURITIES TRUST0.15%484,000--Jan 31, 2024
JANUS INVESTMENT FUND0.13%41,361,417--Dec 31, 2023
FIDELITY MT VERNON STREET TRUST0.12%3,499,791-73,984-2.07%Feb 29, 2024
Brinker Capital Destinations Trust0.12%7,460,000--Feb 29, 2024
Fidelity Central Investment Portfolios II LLC0.12%57,498,000--Mar 31, 2024
JANUS ASPEN SERIES0.12%5,233,333--Dec 31, 2023
JOHN HANCOCK SOVEREIGN BOND FUND0.11%33,864,000--Feb 29, 2024
Voya INTERMEDIATE BOND PORTFOLIO0.11%5,000,000--Mar 31, 2024
MASSMUTUAL PREMIER FUNDS0.10%2,930,234--Dec 31, 2023
Guardian Variable Products Trust0.09%1,474,455--Mar 31, 2024
FIDELITY INCOME FUND /MA/0.08%44,148,000--Feb 29, 2024
AIM INVESTMENT SECURITIES FUNDS (INVESCO INVESTMENT SECURITIES FUNDS)0.08%7,254,319--Feb 29, 2024
FIDELITY GARRISON STREET TRUST0.08%3,430,000--Mar 31, 2024
INVESCO ACTIVELY MANAGED EXCHANGE-TRADED FUND TRUST0.08%3,440,3951,641,56091.26%Jan 31, 2024
Fidelity Merrimack Street Trust0.08%7,860,000--Feb 29, 2024
JANUS INVESTMENT FUND0.08%23,586,369--Dec 31, 2023
GPS Funds I0.08%407,932-113,041-21.70%Mar 31, 2024
VANGUARD VALLEY FORGE FUNDS0.07%38,420--Mar 31, 2024
Fidelity Central Investment Portfolios II LLC0.07%33,561,000--Mar 31, 2024
Variable Insurance Products Fund V0.07%8,679,003--Mar 31, 2024
JOHN HANCOCK SOVEREIGN BOND FUND0.07%19,530,633--Feb 29, 2024
AIM INVESTMENT SECURITIES FUNDS (INVESCO INVESTMENT SECURITIES FUNDS)0.06%5,701,226--Feb 29, 2024
JOHN HANCOCK INCOME SECURITIES TRUST0.06%216,253--Jan 31, 2024
JOHN HANCOCK BOND TRUST0.06%4,271,000--Feb 29, 2024
LORD ABBETT GLOBAL FUND INC0.06%100,000--Mar 31, 2024
FIDELITY GARRISON STREET TRUST0.06%2,383,000--Mar 31, 2024
JANUS INVESTMENT FUND0.06%17,693,463--Dec 31, 2023
Hartford Funds Exchange-Traded Trust0.06%3,263,460--Jan 31, 2024
VANGUARD WELLESLEY INCOME FUND0.06%19,433,319--Mar 31, 2024
LORD ABBETT INVESTMENT TRUST0.05%52,370,000--Feb 29, 2024
FIDELITY GARRISON STREET TRUST0.05%2,199,143--Mar 31, 2024
Brinker Capital Destinations Trust0.05%3,179,908--Feb 29, 2024
FIDELITY INCOME FUND /MA/0.05%26,395,000--Feb 29, 2024
Fidelity Central Investment Portfolios II LLC0.05%23,546,066--Mar 31, 2024
Catholic Responsible Investments Funds0.05%1,867,643--Jan 31, 2024
Fidelity Rutland Square Trust II0.05%59,110,997--Feb 29, 2024
FIDELITY INCOME FUND /MA/0.05%24,584,083--Feb 29, 2024
Voya FUNDS TRUST0.04%12,000,000--Mar 31, 2024
JANUS ASPEN SERIES0.04%1,854,000--Dec 31, 2023
Fidelity Central Investment Portfolios II LLC0.04%19,262,000--Mar 31, 2024
JOHN HANCOCK INVESTMENT TRUST0.04%3,345,000--Mar 31, 2024
Variable Insurance Products Fund V0.04%4,964,000--Mar 31, 2024
FIDELITY SELECT PORTFOLIOS0.03%2,258,063--Feb 29, 2024
LORD ABBETT BOND DEBENTURE FUND INC0.03%37,340,000--Mar 31, 2024
JOHN HANCOCK INCOME SECURITIES TRUST0.03%114,024--Jan 31, 2024
LORD ABBETT INVESTMENT TRUST0.03%32,536,311--Feb 29, 2024
TRUST FOR PROFESSIONAL MANAGERS0.03%10,650,000--Mar 31, 2024
John Hancock Exchange-Traded Fund Trust0.03%201,508--Jan 31, 2024
ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST0.03%1,784,090--Dec 31, 2023
JANUS INVESTMENT FUND0.03%10,000,000--Dec 31, 2023
FIDELITY GARRISON STREET TRUST0.03%1,335,000--Mar 31, 2024
JOHN HANCOCK BOND TRUST0.03%2,127,147--Feb 29, 2024
LORD ABBETT SERIES FUND INC0.03%1,980,000--Mar 31, 2024
LORD ABBETT SERIES FUND INC0.03%1,965,940--Mar 31, 2024
JOHN HANCOCK BOND TRUST0.03%1,975,770--Feb 29, 2024
Variable Insurance Products Fund V0.03%3,728,166--Mar 31, 2024
AIM COUNSELOR SERIES TRUST (INVESCO COUNSELOR SERIES TRUST)0.03%6,679,282--Feb 29, 2024
FIDELITY INCOME FUND /MA/0.03%14,790,000--Feb 29, 2024
ANCHOR SERIES TRUST0.03%895,000--Sep 30, 2021
FIDELITY ADVISOR SERIES II0.03%3,997,739--Feb 29, 2024
FIDELITY SALEM STREET TRUST0.03%110,000,000--Feb 29, 2024
FEDERATED HERMES INSURANCE SERIES0.03%120,600--Mar 31, 2024
Brinker Capital Destinations Trust0.03%1,619,934-0.00%Feb 29, 2024
Fidelity Rutland Square Trust II0.02%29,353,000--Feb 29, 2024
AMERICAN CENTURY INVESTMENT TRUST0.02%3,337,183275,2318.99%Mar 31, 2024
JANUS INVESTMENT FUND0.02%7,214,000--Dec 31, 2023
Forethought Variable Insurance Trust0.02%98,297--Mar 28, 2024
FIRST TRUST EXCHANGE-TRADED FUND IV0.02%5,250,000--Jan 31, 2024
VANGUARD WELLINGTON FUND0.02%9,146,537--Feb 29, 2024
Variable Insurance Products Fund V0.02%2,823,000--Mar 31, 2024
Columbia Funds Variable Series Trust II0.02%688,079--Mar 31, 2024
LORD ABBETT BOND DEBENTURE FUND INC0.02%22,510,016--Mar 31, 2024
DOMINI INVESTMENT TRUST0.02%117,956--Jan 31, 2024
Fidelity Merrimack Street Trust0.02%1,986,000--Feb 29, 2024
PRINCIPAL VARIABLE CONTRACTS FUNDS INC0.02%800,000--Mar 31, 2024
AIM COUNSELOR SERIES TRUST (INVESCO COUNSELOR SERIES TRUST)0.02%4,546,236--Feb 29, 2024
Catholic Responsible Investments Funds0.02%737,227--Jan 31, 2024
USAA MUTUAL FUNDS TRUST0.02%4,423,365--Jan 31, 2024
JOHN HANCOCK INVESTMENT TRUST0.02%1,543,263--Mar 31, 2024
Fidelity Merrimack Street Trust0.02%1,774,261--Feb 29, 2024
JOHN HANCOCK SOVEREIGN BOND FUND0.02%5,042,636--Feb 29, 2024
MAINSTAY VP FUNDS TRUST0.02%2,072,101--Mar 31, 2024
FIDELITY SALEM STREET TRUST0.02%65,580,432--Feb 29, 2024
GUGGENHEIM FUNDS TRUST0.02%8,846,731--Dec 31, 2023
PRINCIPAL VARIABLE CONTRACTS FUNDS INC0.02%638,930--Mar 31, 2024
FIDELITY SALEM STREET TRUST0.02%62,549,000--Feb 29, 2024
Fidelity Rutland Square Trust II0.01%17,197,450--Feb 29, 2024
Fidelity Central Investment Portfolios II LLC0.01%6,416,829--Mar 31, 2024
PROFESSIONALLY MANAGED PORTFOLIOS0.01%982,970--Feb 29, 2024
Fidelity Central Investment Portfolios II LLC0.01%5,605,878--Mar 31, 2024
MML Series Investment Fund II0.01%2,267,712--Dec 31, 2023

aTyr Pharma's largest mutual fund holder by % of total assets is "BNY Mellon U.S. Mortgage Fund, Inc.", owning 2.58M shares, compromising 0.80% of its total assets.

aTyr Pharma Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
30 Jun, 2422-62.07%
31 Mar, 245820.83%
31 Dec, 23489.09%
30 Sep, 2344-2.22%
30 Jun, 234515.38%
31 Mar, 2339-
31 Dec, 223911.43%
30 Sep, 2235-7.89%
30 Jun, 2238-15.56%
31 Mar, 2245-11.76%
31 Dec, 2151-
30 Sep, 2151104.00%
30 Jun, 212531.58%
31 Mar, 2119-
31 Dec, 2019-5.00%
30 Sep, 2020-4.76%
30 Jun, 2021-
31 Mar, 202150.00%
31 Dec, 1914-6.67%
30 Sep, 1915200.00%
30 Jun, 195-

As of 30 Jun 24, 22 institutions are holding aTyr Pharma's shares, representing a decrease of -62.07% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
30 Jun, 2433,928,397-18.84%
31 Mar, 2441,806,0111.40%
31 Dec, 2341,229,92411.03%
30 Sep, 2337,134,5554.11%
30 Jun, 2335,668,4304.67%
31 Mar, 2334,075,89785.66%
31 Dec, 2218,353,688-3.71%
30 Sep, 2219,060,2001.56%
30 Jun, 2218,768,346-4.38%
31 Mar, 2219,627,641-4.51%
31 Dec, 2120,554,8539.19%
30 Sep, 2118,824,963177.34%
30 Jun, 216,787,71117.44%
31 Mar, 215,779,5310.28%
31 Dec, 205,763,5782.29%
30 Sep, 205,634,8192.97%
30 Jun, 205,472,1696.99%
31 Mar, 205,114,483185.06%
31 Dec, 191,794,1573.87%
30 Sep, 191,727,317225.68%
30 Jun, 19530,377-

aTyr Pharma (LIFE) has 33.93M shares outstanding as of 30 Jun 24, down -18.84% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
30 Jun, 2451.34%0.84%
31 Mar, 2477.99%1.54%
31 Dec, 2371.23%1.57%
30 Sep, 2367.34%0.93%
30 Jun, 2385.13%1.29%
31 Mar, 2381.33%2.05%
31 Dec, 2263.04%1.43%
30 Sep, 2266.50%1.49%
30 Jun, 2266.88%1.34%
31 Mar, 2270.56%1.29%
31 Dec, 2173.96%0.69%
30 Sep, 21103.67%5.85%
30 Jun, 2142.09%2.51%
31 Mar, 2140.98%1.38%
31 Dec, 2054.51%1.60%
30 Sep, 2058.40%1.71%
30 Jun, 2058.48%1.06%
31 Mar, 2074.32%3.50%
31 Dec, 1946.11%2.29%
30 Sep, 1944.91%16.81%
30 Jun, 1916.34%-

As of 30 Jun 24, aTyr Pharma is held by 51.34% institutional shareholders, representing a 0.84% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
30 Jun, 2412-66.67%
31 Mar, 243650.00%
31 Dec, 232460.00%
30 Sep, 2315-50.00%
30 Jun, 233025.00%
31 Mar, 232420.00%
31 Dec, 222017.65%
30 Sep, 221730.77%
30 Jun, 2213-38.10%
31 Mar, 2221-22.22%
31 Dec, 2127-25.00%
30 Sep, 2136125.00%
30 Jun, 211623.08%
31 Mar, 211318.18%
31 Dec, 2011-
30 Sep, 201110.00%
30 Jun, 2010-41.18%
31 Mar, 2017112.50%
31 Dec, 198-20.00%
30 Sep, 1910100.00%
30 Jun, 195-

12 institutional shareholders have increased their position in LIFE stock as of 30 Jun 24 compared to 36 in the previous quarter (a -66.67% decrease).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
30 Jun, 244-60.00%
31 Mar, 2410-
31 Dec, 2310-44.44%
30 Sep, 2318157.14%
30 Jun, 237-
31 Mar, 237-12.50%
31 Dec, 22860.00%
30 Sep, 225-54.55%
30 Jun, 221110.00%
31 Mar, 2210-23.08%
31 Dec, 2113160.00%
30 Sep, 21525.00%
30 Jun, 214-
31 Mar, 214-
31 Dec, 204100.00%
30 Sep, 202-50.00%
30 Jun, 204-
31 Mar, 20--100.00%
31 Dec, 193-40.00%
30 Sep, 195-
30 Jun, 19--

4 institutional shareholders have reduced their position in LIFE stock as of 30 Jun 24 compared to 10 in the previous quarter (a -60.00% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
30 Jun, 2422-62.07%33,928,397-18.84%51.34%0.84%12-66.67%4-60.00%
31 Mar, 245820.83%41,806,0111.40%77.99%1.54%3650.00%10-
31 Dec, 23489.09%41,229,92411.03%71.23%1.57%2460.00%10-44.44%
30 Sep, 2344-2.22%37,134,5554.11%67.34%0.93%15-50.00%18157.14%
30 Jun, 234515.38%35,668,4304.67%85.13%1.29%3025.00%7-
31 Mar, 2339-34,075,89785.66%81.33%2.05%2420.00%7-12.50%
31 Dec, 223911.43%18,353,688-3.71%63.04%1.43%2017.65%860.00%
30 Sep, 2235-7.89%19,060,2001.56%66.50%1.49%1730.77%5-54.55%
30 Jun, 2238-15.56%18,768,346-4.38%66.88%1.34%13-38.10%1110.00%
31 Mar, 2245-11.76%19,627,641-4.51%70.56%1.29%21-22.22%10-23.08%
31 Dec, 2151-20,554,8539.19%73.96%0.69%27-25.00%13160.00%
30 Sep, 2151104.00%18,824,963177.34%103.67%5.85%36125.00%525.00%
30 Jun, 212531.58%6,787,71117.44%42.09%2.51%1623.08%4-
31 Mar, 2119-5,779,5310.28%40.98%1.38%1318.18%4-
31 Dec, 2019-5.00%5,763,5782.29%54.51%1.60%11-4100.00%
30 Sep, 2020-4.76%5,634,8192.97%58.40%1.71%1110.00%2-50.00%
30 Jun, 2021-5,472,1696.99%58.48%1.06%10-41.18%4-
31 Mar, 202150.00%5,114,483185.06%74.32%3.50%17112.50%--100.00%
31 Dec, 1914-6.67%1,794,1573.87%46.11%2.29%8-20.00%3-40.00%
30 Sep, 1915200.00%1,727,317225.68%44.91%16.81%10100.00%5-
30 Jun, 195-530,377-16.34%-5---

aTyr Pharma Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jun 03, 2024COUGHLIN TIMOTHYdirector-P-PurchaseBuy50,000$1.75$87.50K56,000
Jun 03, 2024Broadfoot Jill Marieofficer Chief Financial OfficerP-PurchaseBuy5,000$1.79$8.95K27,960
Jun 03, 2024Shukla Sanjaydirector, officer President and CEOP-PurchaseBuy20,000$1.81$36.14K136,548
Feb 06, 2024Broadfoot Jill Marieofficer Chief Financial OfficerS-SaleSell1,590$1.69$2.69K20,821
Dec 12, 2023Shukla Sanjaydirector, officer President and CEOP-PurchaseBuy12,000$1.18$14.14K106,173

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jun 03, 2024COUGHLIN TIMOTHYdirector-P-PurchaseBuy50,000$1.75$87.50K56,000
Jun 03, 2024Broadfoot Jill Marieofficer Chief Financial OfficerP-PurchaseBuy5,000$1.79$8.95K27,960
Jun 03, 2024Shukla Sanjaydirector, officer President and CEOP-PurchaseBuy20,000$1.81$36.14K136,548
Dec 12, 2023Shukla Sanjaydirector, officer President and CEOP-PurchaseBuy12,000$1.18$14.14K106,173

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Feb 06, 2024Shukla Sanjaydirector, officer President and CEOM-ExemptSell10,375--20,750
Feb 06, 2024Broadfoot Jill Marieofficer Chief Financial OfficerS-SaleSell1,590$1.69$2.69K20,821
Feb 06, 2024Broadfoot Jill Marieofficer Chief Financial OfficerM-ExemptSell3,750--7,500
Feb 06, 2024DENYES NANCYofficer General CounselM-ExemptSell2,688--5,374

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jun 03, 2024COUGHLIN TIMOTHYdirector-P-PurchaseBuy50,000$1.75$87.50K56,000
Jun 03, 2024Broadfoot Jill Marieofficer Chief Financial OfficerP-PurchaseBuy5,000$1.79$8.95K27,960
Jun 03, 2024Shukla Sanjaydirector, officer President and CEOP-PurchaseBuy20,000$1.81$36.14K136,548
May 23, 2024CLARKE JOHN Kdirector-A-AwardBuy24,000$1.86$44.64K24,000
May 23, 2024Gross Jane Adirector-A-AwardBuy24,000$1.86$44.64K24,000
May 23, 2024Lucas Svetlanadirector-A-AwardBuy24,000$1.86$44.64K24,000
May 23, 2024SCHIMMEL PAULdirector-A-AwardBuy24,000$1.86$44.64K24,000
May 23, 2024Zaknoen Saradirector-A-AwardBuy24,000$1.86$44.64K24,000
May 23, 2024COUGHLIN TIMOTHYdirector-A-AwardBuy24,000$1.86$44.64K24,000
Feb 06, 2024Shukla Sanjaydirector, officer President and CEOM-ExemptBuy10,375--116,548
Feb 06, 2024Shukla Sanjaydirector, officer President and CEOM-ExemptSell10,375--20,750
Feb 06, 2024Broadfoot Jill Marieofficer Chief Financial OfficerM-ExemptBuy3,750--22,411
Feb 06, 2024Broadfoot Jill Marieofficer Chief Financial OfficerS-SaleSell1,590$1.69$2.69K20,821
Feb 06, 2024Broadfoot Jill Marieofficer Chief Financial OfficerM-ExemptSell3,750--7,500
Feb 06, 2024DENYES NANCYofficer General CounselM-ExemptBuy2,688--14,767
Feb 06, 2024DENYES NANCYofficer General CounselM-ExemptSell2,688--5,374
Jan 09, 2024Shukla Sanjaydirector, officer President and CEOA-AwardBuy600,000$1.50$900.00K600,000
Jan 09, 2024Broadfoot Jill Marieofficer Chief Financial OfficerA-AwardBuy150,000$1.50$225.00K150,000
Jan 09, 2024DENYES NANCYofficer General CounselA-AwardBuy150,000$1.50$225.00K150,000
Dec 12, 2023Shukla Sanjaydirector, officer President and CEOP-PurchaseBuy12,000$1.18$14.14K106,173

The last insider sell of aTyr Pharma's stock was made by Shukla Sanjay on Feb 06 2024, selling 10,375 shares at - per share (valued at -). The last insider buy of LIFE was made by COUGHLIN TIMOTHY on Jun 03 2024, buying 50,000 shares at $1.75 per share (worth $87.50K).

aTyr Pharma Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 20246--
Q1 202464150.00%
Q4 20234--
Q3 20231--
Q2 2023147200.00%
Q1 202364150.00%
Q4 20221--
Q3 20221--
Q2 20229--
Q1 20228--
Q4 20211--
Q3 202121200.00%
Q2 20211111100.00%
Q1 202164150.00%
Q3 2020-4-
Q2 2020133433.33%
Q1 202064150.00%
Q2 2019102500.00%
Q1 201951050.00%
Q4 20183--

6 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by aTyr Pharma's insiders, as of Q2 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 2024---
Q1 2024-1-
Q4 20234--
Q3 20231--
Q2 20231--
Q1 2023-1-
Q4 20221--
Q3 20221--
Q2 2022---
Q1 20222--
Q4 20211--
Q3 20211--
Q2 202121200.00%
Q1 2021-2-
Q3 2020-4-
Q2 202022100.00%
Q1 20201250.00%
Q2 2019-1-
Q1 2019---
Q4 20183--

As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of aTyr Pharma's stocks.

aTyr Pharma Peer Ownership


TickerCompany
XFORX4 Pharmaceuticals, Inc.
MREOMereo BioPharma Group plc
DAWNDay One Biopharmaceuticals, Inc.
PDSBPDS Biotechnology Corporation
HOOKHOOKIPA Pharma Inc.
TERNTerns Pharmaceuticals, Inc.
INZYInozyme Pharma, Inc.
ABOSAcumen Pharmaceuticals, Inc.
AMLXAmylyx Pharmaceuticals, Inc.

LIFE Ownership FAQ


aTyr Pharma is owned by institutional shareholders (51.34%), insiders (2.62%), and public (46.04%). The largest institutional shareholder of aTyr Pharma is FEDERATED HERMES, INC. (22.20% of total shares) and the top mutual fund owner is BNY Mellon U.S. Mortgage Fund, Inc. (0.80% of total shares).

aTyr Pharma's major institutional shareholders are FEDERATED HERMES, INC., FMR LLC, LOGOS GLOBAL MANAGEMENT LP, VANGUARD GROUP INC, and TIKVAH MANAGEMENT LLC. The top five shareholders own together 50.14% of the company's share outstanding.

As of Jun 2024, there are 22 institutional shareholders of aTyr Pharma.

FEDERATED HERMES, INC owns 14.67M shares of aTyr Pharma, representing 22.20% of the company's total shares outstanding, valued at $22.88B (as of Jun 2024).

As of Jun 2024, FMR LLC holds 10.35M shares of aTyr Pharma (LIFE), compromising 15.67% of the company, valued at $16.15M.

LOGOS GLOBAL MANAGEMENT LP is the third largest holder of aTyr Pharma. The company owns 3M of the company's shares outstanding (worth $4.68M).